BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22630048)

  • 1. Effect of melt sonocrystallization on pharmacotechnical properties of paracetamol, indomethacin and mefenamic acid characterized by dynamic laser scattering and its impact on solubility.
    Kumar B; Sharma V; Pathak K
    Drug Dev Ind Pharm; 2013 May; 39(5):687-95. PubMed ID: 22630048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melt sonocrystallized piroxicam for oral delivery: particle characterization, solid state analysis, and pharmacokinetics.
    Gupta PS; Sharma V; Pathak K
    Expert Opin Drug Deliv; 2013 Jan; 10(1):17-32. PubMed ID: 23102052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of the thermal, spectroscopic and drug dissolution properties of mefenamic acid and polyoxyethylene-polyoxypropylene solid dispersions.
    Andrews GP; Zhai H; Tipping S; Jones DS
    J Pharm Sci; 2009 Dec; 98(12):4545-56. PubMed ID: 19399827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A; Cavallari C; Ospitali F
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comminution of ibuprofen to produce nano-particles for rapid dissolution.
    Plakkot S; de Matas M; York P; Saunders M; Sulaiman B
    Int J Pharm; 2011 Aug; 415(1-2):307-14. PubMed ID: 21683776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elaboration and structural analysis of aquasomes loaded with indomethacin.
    Rojas-Oviedo I; Salazar-López RA; Reyes-Gasga J; Quirino-Barreda CT
    Eur J Pharm Sci; 2007 Nov; 32(3):223-30. PubMed ID: 17905573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melt sonocrystallization of ibuprofen: effect on crystal properties.
    Manish M; Harshal J; Anant P
    Eur J Pharm Sci; 2005 May; 25(1):41-8. PubMed ID: 15854799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous micronization and surface modification for improvement of flow and dissolution of drug particles.
    Han X; Ghoroi C; To D; Chen Y; Davé R
    Int J Pharm; 2011 Aug; 415(1-2):185-95. PubMed ID: 21664954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
    Maghsoodi M; Sadeghpoor F
    Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryomilling-induced solid dispersion of poor glass forming/poorly water-soluble mefenamic acid with polyvinylpyrrolidone K12.
    Kang N; Lee J; Choi JN; Mao C; Lee EH
    Drug Dev Ind Pharm; 2015 Jun; 41(6):978-88. PubMed ID: 24849785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid-state characterization of mefenamic acid.
    Panchagnula R; Sundaramurthy P; Pillai O; Agrawal S; Raj YA
    J Pharm Sci; 2004 Apr; 93(4):1019-29. PubMed ID: 14999737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
    Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives.
    Cho E; Cho W; Cha KH; Park J; Kim MS; Kim JS; Park HJ; Hwang SJ
    Int J Pharm; 2010 Aug; 396(1-2):91-8. PubMed ID: 20558265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of indomethacin-saccharin (IMC-SAC) co-crystals prepared by an anti-solvent crystallization process.
    Chun NH; Wang IC; Lee MJ; Jung YT; Lee S; Kim WS; Choi GJ
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):854-61. PubMed ID: 23454054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tablet preformulations of indomethacin-loaded mesoporous silicon microparticles.
    Tahvanainen M; Rotko T; Mäkilä E; Santos HA; Neves D; Laaksonen T; Kallonen A; Hämäläinen K; Peura M; Serimaa R; Salonen J; Hirvonen J; Peltonen L
    Int J Pharm; 2012 Jan; 422(1-2):125-31. PubMed ID: 22063301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporation of indomethacin nanoparticles into 3-D ordered macroporous silica for enhanced dissolution and reduced gastric irritancy.
    Hu Y; Zhi Z; Wang T; Jiang T; Wang S
    Eur J Pharm Biopharm; 2011 Nov; 79(3):544-51. PubMed ID: 21767643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of submicron-sized niflumic acid crystals prepared by electrospray crystallization.
    Ambrus R; Radacsi N; Szunyogh T; van der Heijden AE; Ter Horst JH; Szabó-Révész P
    J Pharm Biomed Anal; 2013 Mar; 76():1-7. PubMed ID: 23287488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some physicochemical properties of mefenamic acid.
    Adam A; Schrimpl L; Schmidt PC
    Drug Dev Ind Pharm; 2000 May; 26(5):477-87. PubMed ID: 10789059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and evaluation of celecoxib porous particles using melt sonocrystallization.
    Paradkar A; Maheshwari M; Kamble R; Grimsey I; York P
    Pharm Res; 2006 Jun; 23(6):1395-400. PubMed ID: 16741659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of a crystalline salt of indomethacin and tromethamine by hot melt extrusion technology.
    Bookwala M; Thipsay P; Ross S; Zhang F; Bandari S; Repka MA
    Eur J Pharm Biopharm; 2018 Oct; 131():109-119. PubMed ID: 30086393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.